Utah Current Deferred Revenue from 2010 to 2024
| UTMD Stock | USD 65.97 0.68 1.04% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 327 K | Current Value 232.6 K | Quarterly Volatility 1.1 M |
Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.7 M, Interest Expense of 669.3 K or Total Revenue of 36.6 M, as well as many indicators such as Price To Sales Ratio of 3.45, Dividend Yield of 0.0243 or PTB Ratio of 4.36. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
Utah | Current Deferred Revenue |
Latest Utah Medical's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Utah Medical Products over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Utah Medical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Utah Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 382,643 | |
| Geometric Mean | 166,201 | |
| Coefficient Of Variation | 278.02 | |
| Mean Deviation | 743,743 | |
| Median | (38,000) | |
| Standard Deviation | 1,063,841 | |
| Sample Variance | 1.1T | |
| Range | 3.6M | |
| R-Value | (0.47) | |
| Mean Square Error | 945.2B | |
| R-Squared | 0.22 | |
| Significance | 0.07 | |
| Slope | (112,713) | |
| Total Sum of Squares | 15.8T |
Utah Current Deferred Revenue History
About Utah Medical Financial Statements
Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 327 K | 232.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out the analysis of Utah Medical Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.2 | Earnings Share 4.28 | Revenue Per Share 12.392 | Quarterly Revenue Growth (0.20) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.